SCHEMBL3424110

SCHEMBL3424110

Cc1cc(NC(=O)C(C)(C)NC(=O)c2ccc(Cl)s2)ccc1C(=O)N1CCC[C@H]1CO

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 8/20 0.72
AR P10275 3/20 0.52
RAB9A P51151 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CNR2 P34972 1/20 0.39
HSD11B1 P28845 1/20 0.39
AVPR2 P30518 2/20 0.36
AVPR1A P37288 2/20 0.36
ABCB11 O95342 1/20 0.36
ADRB2 P07550 1/20 0.36
HTR1A P08908 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
HTR2C P28335 1/20 0.36
HRH1 P35367 1/20 0.36
OPRM1 P35372 1/20 0.36
GLP1R P43220 1/20 0.36
TMEM97 Q5BJF2 1/20 0.36
FFAR4 Q5NUL3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3428529 1.00 F10 (0.72) F10ARRAB9ATDP1CNR2
SCHEMBL8283890 0.91 F10 (0.69) F10ARHSD11B1AVPR2AVPR1A
SCHEMBL3426597 0.91 F10 (0.72) F10ARHSD11B1AVPR2
SCHEMBL3427822 0.91 F10 (0.69) F10ARHSD11B1AVPR2AVPR1A
SCHEMBL3427567 0.91 F10 (0.69) F10ARHSD11B1AVPR2AVPR1A
SCHEMBL3429499 0.91 F10 (0.74) F10ARRAB9AHSD11B1
SCHEMBL3426460 0.90 F10 (0.58) F10ARRAB9ATDP1CNR2
SCHEMBL3422019 0.90 F10 (0.70) F10ARRAB9ATDP1HSD11B1
SCHEMBL3426390 0.89 F10 (0.66) F10ARRAB9AHSD11B1AVPR2
SCHEMBL3426605 0.89 F10 (0.66) F10ARRAB9AHSD11B1AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-7732466-B2 Substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-06-08 US disclosed
US-20060293300-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060293300-A1 New substituted thiophene carboxamides, process for their preparation and their use as medicaments OTC, TPMT, ABCG2 F10 1901/4885AR 3491/4885RAB9A 3277/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.